Virginia Retirement Systems Et Al Deciphera Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$12.46 - $15.48 $74,760 - $92,880	6,000 Added 8.0%	81,000 $1.03 Million
Q2 2023 Aug 22, 2023	SELL	$13.28 - $15.96 $118,192 - $142,044	-8,900 Reduced 10.61%	75,000 $1.06 Million
Q1 2023 Jul 11, 2023	BUY	$14.26 - $22.1 $86,986 - $134,810	6,100 Added 7.84%	83,900 $1.3 Million
Q4 2022 May 17, 2023	BUY	$14.85 - $19.04 $782,595 - $1 Million	52,700 Added 209.96%	77,800 $1.28 Billion
Q3 2022 May 16, 2023	BUY	$12.38 - $20.23 $310,738 - $507,773	25,100 New	25,100 $464 Million

212K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.